European Journal of Therapeutics (Eur J Ther) is the doubleblind peer-reviewed, open access, international publication
organ of the Gaziantep University School of Medicine. The
journal is a quarterly publication, published on March, June,
September, and December and its publication language is
English.
European Journal of Therapeutics aims to contribute to the
international literature by publishing original clinical and
experimental research articles, short communication, review
articles, technical notes, and letters to the editor in the fields
of medical sciences. The journal’s target audience includes
researchers, physicians and healthcare professionals who are
interested or working in in all medical disciplines.
The editorial and publication processes of the journal are
shaped in accordance with the guidelines of the International
Council of Medical Journal Editors (ICMJE), the World
Association of Medical Editors (WAME), the Council of Science
Editors (CSE), the Committee on Publication Ethics (COPE), the
European Association of Science Editors (EASE), and National
Information Standards Organization (NISO). The journal
conforms to the Principles of Transparency and Best Practice
in Scholarly Publishing (doaj.org/bestpractice).
Originality, high scientific quality, and citation potential are
the most important criteria for a manuscript to be accepted
for publication. Manuscripts submitted for evaluation should
not have been previously presented or already published in an
electronic or printed medium. The journal should be informed
of manuscripts that have been submitted to another journal
for evaluation and rejected for publication. The submission of
previous reviewer reports will expedite the evaluation process.
Manuscripts that have been presented in a meeting should
be submitted with detailed information on the organization,
including the name, date, and location of the organization.
Manuscripts submitted to European Journal of Therapeutics
will go through a double-blind peer-review process. Each
submission will be reviewed by at least two external,
independent peer reviewers who are experts in their fields in
order to ensure an unbiased evaluation process. The editorial
board will invite an external and independent editor to manage
the evaluation processes of manuscripts submitted by editors
or by the editorial board members of the journal. The Editor
in Chief is the final authority in the decision-making process
for all submissions.
An approval of research protocols by the Ethics Committee
in accordance with international agreements (World Medical
Association Declaration of Helsinki “Ethical Principles for
Medical Research Involving Human Subjects,” amended in
October 2013, www.wma.net) is required for experimental,
clinical, and drug studies and for some case reports. If
required, ethics committee reports or an equivalent official
document will be requested from the authors. For manuscripts
concerning experimental research on humans, a statement
should be included that shows that written informed consent
of patients and volunteers was obtained following a detailed
explanation of the procedures that they may undergo. For
studies carried out on animals, the measures taken to prevent
pain and suffering of the animals should be stated clearly.
Information on patient consent, the name of the ethics
committee, and the ethics committee approval number should
also be stated in the Materials and Methods section of the
manuscript. It is the authors’ responsibility to carefully protect
the patients’ anonymity. For photographs that may reveal the
identity of the patients, signed releases of the patient or of
their legal representative should be enclosed.
All submissions are screened by a similarity detection software
(iThenticate by CrossCheck).
In the event of alleged or suspected research misconduct,
e.g., plagiarism, citation manipulation, and data falsification/
fabrication, the Editorial Board will follow and act in accordance
with COPE guidelines.
Each individual listed as an author should fulfill the authorship
criteria recommended by the International Committee of
Medical Journal Editors
(ICMJE - www.icmje.org). The ICMJE recommends that
authorship be based on the following 4 criteria:
1 Substantial contributions to the conception or design of
the work; or the acquisition, analysis, or interpretation of
data for the work; AND
2 Drafting the work or revising it critically for important
intellectual content; AND
3 Final approval of the version to be published; AND
4 Agreement to be accountable for all aspects of the
work in ensuring that questions related to the accuracy
or integrity of any part of the work are appropriately
investigated and resolved.
In addition to being accountable for the parts of the work he/
she has done, an author should be able to identify which coauthors are responsible for specific other parts of the work.
In addition, authors should have confidence in the integrity of
the contributions of their co-authors.
All those designated as authors should meet all four criteria
for authorship, and all who meet the four criteria should be
identified as authors. Those who do not meet all four criteria
should be acknowledged in the title page of the manuscript.
European Journal of Therapeutics requires corresponding
authors to submit a signed and scanned version of the Copyright
Agreement and Acknowledgement of Authorship Form
(available for download through www.eurjther.com) during
the initial submission process in order to act appropriately on
authorship rights and to prevent ghost or honorary authorship.
If the editorial board suspects a case of “gift authorship,”
the submission will be rejected without further review. As
part of the submission of the manuscript, the corresponding
author should also send a short statement declaring that he/
European Journal of
Therapeutics
OFFICIAL JOURNAL OF GAZİANTEP UNIVERSITY FACULTY OF MEDICINE
GAZİANTEP UNIVERSITY
1973
A-III
she accepts to undertake all the responsibility for authorship
during the submission and review stages of the manuscript.
European Journal of Therapeutics requires and encourages
the authors and the individuals involved in the evaluation
process of submitted manuscripts to disclose any existing or
potential conflicts of interests, including financial, consultant,
and institutional, that might lead to potential bias or a conflict
of interest. Any financial grants or other support received for
a submitted study from individuals or institutions should be
disclosed to the Editorial Board. To disclose a potential conflict
of interest, the ICMJE Potential Conflict of Interest Disclosure
Form should be filled in and submitted by all contributing
authors. Cases of a potential conflict of interest of the editors,
authors, or reviewers are resolved by the journal’s Editorial
Board within the scope of COPE and ICMJE guidelines.
The Editorial Board of the journal handles all appeal and
complaint cases within the scope of COPE guidelines. In such
cases, authors should get in direct contact with the editorial
office regarding their appeals and complaints. When needed,
an ombudsperson may be assigned to resolve cases that cannot
be resolved internally. The Editor in Chief is the final authority
in the decision-making process for all appeals and complaints.
European Journal of Therapeutics requires each submission
to be accompanied by a Copyright Agreement and
Acknowledgement of Authorship Form (available for
download at www. eurjther.com). When using previously
published content, including figures, tables, or any other
material in both print and electronic formats, authors must
obtain permission from the copyright holder. Legal, financial
and criminal liabilities in this regard belong to the author(s).
By signing this form, authors agree that the article, if accepted
for publication by the European Journal of Therapeutics, will
be licensed under a Creative Commons Attribution-Non
Commercial 4.0 International License (CC-BY-NC).
Statements or opinions expressed in the manuscripts
published in European Journal of Medical Sciences reflect the
views of the author(s) and not the opinions of the editors,
the editorial board, or the publisher; the editors, the editorial
board, and the publisher disclaim any responsibility or liability
for such materials. The final responsibility in regard to the
published content rests with the authors.
MANUSCRIPT PREPARATION
The manuscripts should be prepared in accordance with
ICMJE-Recommendations for the Conduct, Reporting,
Editing, and Publication of Scholarly Work in Medical Journals
(updated in December 2019 - http://www.icmje.org/icmjerecommendations.pdf). Authors are required to prepare
manuscripts in accordance with the CONSORT guidelines
for randomized research studies, STROBE guidelines for
observational original research studies, STARD guidelines
for studies on diagnostic accuracy, PRISMA guidelines for
systematic reviews and meta-analysis, ARRIVE guidelines for
experimental animal studies, and TREND guidelines for nonrandomized public behavior.
Manuscripts can only be submitted through the journal’s
online manuscript submission and evaluation system,
available at www.eurjther.com. Manuscripts submitted via any
other medium will not be evaluated.
Manuscripts submitted to the journal will first go through a
technical evaluation process where the editorial office staff will
ensure that the manuscript has been prepared and submitted
in accordance with the journal’s guidelines. Submissions that
do not conform to the journal’s guidelines will be returned to
the submitting author with technical correction requests.
Authors are required to submit the following:
• Copyright Agreement and Acknowledgement of
Authorship Form
• ICMJE Potential Conflict of Interest Disclosure Form
(should be filled in by all contributing authors)
during the initial submission. These forms are available for
download at www.eurjther.com.
Preparation of the Manuscript
Title page: A separate title page should be submitted with all
submissions and this page should include:
• The full title of the manuscript as well as a short title
(running head) of no more than 50 characters,
• Name(s), affiliations, and highest academic degree(s) of
the author(s),
• Grant information and detailed information on the other
sources of support,
• Name, address, telephone (including the mobile phone
number) and fax numbers, and email address of the
corresponding author,
• Acknowledgment of the individuals who contributed to
the preparation of the manuscript but who do not fulfill
the authorship criteria.
Abstract: An abstract should be submitted with all submissions
except for Letters to the Editor. The abstract of Original
Articles should be structured with subheadings (Objective,
Methods, Results, and Conclusion). Please check Table 1
below for word count specifications.
Keywords: Each submission must be accompanied by a
minimum of three to a maximum of six keywords for subject
indexing at the end of the abstract. The keywords should
be listed in full without abbreviations. The keywords should
be selected from the National Library of Medicine, Medical
Subject Headings database (https://www.nlm.nih.gov/mesh/
MBrowser.html).
Main Points: All submissions except letters to the editor
should be accompanied by 3 to 5 “main points” which should
emphasize the most noteworthy results of the study and
underline the principle message that is addressed to the
reader. This section should be structured as itemized to give
a general overview of the article. Since “Main Points” targeting
the experts and specialists of the field, each item should be
written as plain and straightforward as possible.
European Journal of
Therapeutics
OFFICIAL JOURNAL OF GAZİANTEP UNIVERSITY FACULTY OF MEDICINE
GAZİANTEP UNIVERSITY
1973
A-IV
Manuscript Types
Original Articles: This is the most important type of article since
it provides new information based on original research. The main
text of original articles should be structured with Introduction,
Methods, Results, Discussion, and Conclusion subheadings.
Please check Table 1 for the limitations for Original Articles.
Statistical analysis to support conclusions is usually necessary.
Statistical analyses must be conducted in accordance with
international statistical reporting standards (Altman DG, Gore
SM, Gardner MJ, Pocock SJ. Statistical guidelines for contributors
to medical journals. Br Med J 1983: 7; 1489-93). Information
on statistical analyses should be provided with a separate
subheading under the Materials and Methods section and the
statistical software that was used during the process must be
specified.
Units should be prepared in accordance with the International
System of Units (SI).
Editorial Comments: Editorial comments aim to provide a
brief critical commentary by reviewers with expertise or
with high reputation in the topic of the research article
published in the journal. Authors are selected and invited
by the journal to provide such comments. Abstract,
Keywords, and Tables, Figures, Images, and other media
are not included.
Review Articles: Reviews prepared by authors who have
extensive knowledge on a particular field and whose scientific
background has been translated into a high volume of
publications with a high citation potential are welcomed.
These authors may even be invited by the journal. Reviews
should describe, discuss, and evaluate the current level of
knowledge of a topic in clinical practice and should guide
future studies. The main text should contain Introduction,
Clinical and Research Consequences, and Conclusion sections.
Please check Table 1 for the limitations for Review Articles.
Short Communication: This type of manuscript present
significant findings from tangential investigations that are
offshoots from larger studies or from early results that will
have to be confirmed through further study. An unstructured
main text should be prepared for each short communication.
Please check Table 1 for the limitations for Short Note.
Technical Notes: This type of manuscripts should present a
new experimental, computational method, test, procedure,
or comparison of methods. The method described may
either be completely new, or may offer a better version of an
existing method. The technical note article must describe a
demonstrable advance on what is currently available. Please
check Table 1 for the limitations for Technical Notes.
Letters to the Editor: This type of manuscript discusses
important parts, overlooked aspects, or lacking parts of a
previously published article. Articles on subjects within the
scope of the journal that might attract the readers’ attention,
particularly educative cases, may also be submitted in the
form of a “Letter to the Editor.” Readers can also present
their comments on the published manuscripts in the form
of a “Letter to the Editor.” Abstract, Keywords, and Tables,
Figures, Images, and other media should not be included. The
text should be unstructured. The manuscript that is being
commented on must be properly cited within this manuscript.
Table 1. Limitations for each manuscript type
Type of
manuscript
Word
limit
Abstract
word limit
Reference
limit
Table
limit
Figure
limit
Original Article 3500 250
(Structured)
30 6 7 or total of
15 images
Review Article 5000 250 50 6 10 or total of
20 images
Short
Communication
1500 200 20 5 1 or total of
5 images
Technical Note 1500 No abstract 15 No tables 10 or total of
20 images
Letter to the Editor 500 No abstract 5 No tables No media
Tables
Tables should be included in the main document, presented
after the reference list, and they should be numbered
consecutively in the order they are referred to within the
main text. A descriptive title must be placed above the tables.
Abbreviations used in the tables should be defined below
the tables by footnotes (even if they are defined within the
main text). Tables should be created using the “insert table”
command of the word processing software and they should
be arranged clearly to provide easy reading. Data presented
in the tables should not be a repetition of the data presented
within the main text but should be supporting the main text.
Figures and Figure Legends
Figures, graphics, and photographs should be submitted as
separate files (in TIFF or JPEG format) through the submission
system. The files should not be embedded in a Word document
or the main document. When there are figure subunits, the
subunits should not be merged to form a single image.
Each subunit should be submitted separately through the
submission system. Images should not be labeled (a, b, c, etc.)
to indicate figure subunits. Thick and thin arrows, arrowheads,
stars, asterisks, and similar marks can be used on the images
to support figure legends. Like the rest of the submission, the
figures too should be blind. Any information within the images
that may indicate an individual or institution should be blinded.
The minimum resolution of each submitted figure should be 300
DPI. To prevent delays in the evaluation process, all submitted
figures should be clear in resolution and large in size (minimum
dimensions: 100 × 100 mm). Figure legends should be listed at
the end of the main document.
All acronyms and abbreviations used in the manuscript should
be defined at first use, both in the abstract and in the main
text. The abbreviation should be provided in parentheses
following the definition.
European Journal of
Therapeutics
OFFICIAL JOURNAL OF GAZİANTEP UNIVERSITY FACULTY OF MEDICINE
GAZİANTEP UNIVERSITY
1973
A-V
When a drug, product, hardware, or software program is
mentioned within the main text, product information, including
the name of the product, the producer of the product, and city and
the country of the company (including the state if in USA), should
be provided in parentheses in the following format: “Discovery St
PET/CT scanner (General Electric, Milwaukee, WI, USA)”
All references, tables, and figures should be referred to within
the main text, and they should be numbered consecutively in
the order they are referred to within the main text.
Limitations, drawbacks, and the shortcomings of original
articles should be mentioned in the Discussion section before
the conclusion paragraph.
References
While citing publications, preference should be given to the
latest, most up-to-date publications. Authors should avoid
using references that are older than ten years. The limit for
the old reference usage is 15% in the journal. If an ahead-ofprint publication is cited, the DOI number should be provided.
Authors are responsible for the accuracy of references.
Journal titles should be abbreviated in accordance with the
journal abbreviations in Index Medicus/ MEDLINE/PubMed.
When there are six or fewer authors, all authors should be
listed. If there are seven or more authors, the first six authors
should be listed followed by “et al.” In the main text of the
manuscript, references should be cited using Arabic numbers
in parentheses. The reference styles for different types of
publications are presented in the following examples.
Journal Article: Rankovic A, Rancic N, Jovanovic M, Ivanović
M, Gajović O, Lazić Z, et al. Impact of imaging diagnostics
on the budget – Are we spending too much? Vojnosanit Pregl
2013; 70: 709-11.
Book Section: Suh KN, Keystone JS. Malaria and babesiosis.
Gorbach SL, Barlett JG, Blacklow NR, editors. Infectious
Diseases. Philadelphia: Lippincott Williams; 2004.p.2290-308.
Books with a Single Author: Sweetman SC. Martindale the
Complete Drug Reference. 34th ed. London: Pharmaceutical
Press; 2005.
Editor(s) as Author: Huizing EH, de Groot JAM, editors.
Functional reconstructive nasal surgery. Stuttgart-New York:
Thieme; 2003.
Conference Proceedings: Bengisson S. Sothemin BG.
Enforcement of data protection, privacy and security in medical
informatics. In: Lun KC, Degoulet P, Piemme TE, Rienhoff O,
editors. MEDINFO 92. Proceedings of the 7th World Congress
on Medical Informatics; 1992 Sept 6-10; Geneva, Switzerland.
Amsterdam: North-Holland; 1992. pp.1561-5.
Scientific or Technical Report: Cusick M, Chew EY, Hoogwerf
B, Agrón E, Wu L, Lindley A, et al. Early Treatment Diabetic
Retinopathy Study Research Group. Risk factors for renal
replacement therapy in the Early Treatment Diabetic
Retinopathy Study (ETDRS), Early Treatment Diabetic
Retinopathy Study Kidney Int: 2004. Report No: 26.
Thesis: Yılmaz B. Ankara Üniversitesindeki Öğrencilerin
Beslenme Durumları, Fiziksel Aktiviteleri ve Beden Kitle
İndeksleri Kan Lipidleri Arasındaki Ilişkiler. H.Ü. Sağlık Bilimleri
Enstitüsü, Doktora Tezi. 2007.
Manuscripts Accepted for Publication, Not Published Yet:
Slots J. The microflora of black stain on human primary teeth.
Scand J Dent Res. 1974.
Epub Ahead of Print Articles: Cai L, Yeh BM, Westphalen AC,
Roberts JP, Wang ZJ. Adult living donor liver imaging. Diagn
Interv Radiol. 2016 Feb 24. doi: 10.5152/dir.2016.15323.
[Epub ahead of print].
Manuscripts Published in Electronic Format: Morse SS.
Factors in the emergence of infectious diseases. Emerg
Infect Dis (serial online) 1995 Jan-Mar (cited 1996 June 5):
1(1): (24 screens). Available from: URL: http:/ www.cdc.gov/
ncidodlElD/cid.htm.
REVISIONS
When submitting a revised version of a paper, the author must
submit a detailed “Response to the reviewers” that states point
by point how each issue raised by the reviewers has been
covered and where it can be found (each reviewer’s comment,
followed by the author’s reply and line numbers where the
changes have been made) as well as an annotated copy of
the main document. Revised manuscripts must be submitted
within 30 days from the date of the decision letter. If the revised
version of the manuscript is not submitted within the allocated
time, the revision option may be canceled. If the submitting
author(s) believe that additional time is required, they should
request this extension before the initial 30-day period is over.
Accepted manuscripts are copy-edited for grammar,
punctuation, and format. Once the publication process of a
manuscript is completed, it is published online on the journal’s
webpage as an ahead-of-print publication before it is included
in its scheduled issue. A PDF proof of the accepted manuscript is
sent to the corresponding author and their publication approval
is requested within 2 days of their receipt of the proof.